DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Asimadoline is an investigational drug.
There have been 7 clinical trials for Asimadoline. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Irritable Bowel Syndrome, Syndrome, and Pruritus. The leading clinical trial sponsors are Tioga Pharmaceuticals, RTI Health Solutions, and Mayo Clinic.
There are two hundred and thirty-four US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Asimadoline
|Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis||Tioga Pharmaceuticals||Phase 2|
|A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers||Tioga Pharmaceuticals||Phase 1|
|Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)||RTI Health Solutions||Phase 3|
Top disease conditions for Asimadoline
Top clinical trial sponsors for Asimadoline
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Asimadoline||Start Trial||Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof||Start Trial|
|Asimadoline||Start Trial||Ultra-pure agonists of guanylate cyclase C, method of making and using same||SYNERGY PHARMACEUTICALS, INC. (New York, NY)||Start Trial|
|Asimadoline||Start Trial||Synthetic peptide amides and dimers thereof||Cara Therapeutics, Inc. (Stamford, CT)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Asimadoline||European Patent Office||3324975||2035-07-22||Start Trial|
|Asimadoline||World Intellectual Property Organization (WIPO)||2017015309||2035-07-22||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|